Phase I trial of GlaxoSmithKline’s Ebola vaccine shows it is well tolerated No major adverse events were reported in an Ebola vaccine phase I trial involving 20 volunteers.…
New roles explored for nucleoside reverse transcriptase inhibitors New research suggests nucleoside reverse transcriptase inhibitors (NRTIs) have intrinsic anti-inflammatory activity through suppression of NLRP3 inflammasome.…
Community pharmacists could screen at-risk groups for liver disease According to The Lancet’s commission, community pharmacists could play a key role in helping to improve liver disease services in primary care, say hepatology specialists.…
Assessing suspected food poisoning cases in the UK With more than 20,000 patients hospitalised in the UK each year because of food poisoning, quick assessment is essential.…
UNAIDS sets target of 90% of people with HIV receiving treatment by 2020A fast-track approach is needed over the next five years for the AIDS epidemic to cease to be a global health threat by 2030, according to a report by UNAIDS released on 18 November 2014.…
Review points to effectiveness of influenza vaccination Researchers have used “test-negative design” case-control studies to assess the effectiveness of seasonal influenza vaccine.…
Ebola research projects receive £1.34mA hand-held device to test bodily fluids for the Ebola virus is among five new research projects announced by the UK government and the Wellcome Trust.…
Case of bird flu confirmed in UKA case of avian influenza has been confirmed in the UK by the Department for Environment, Food and Rural Affairs.…
Fatal case of progressive multifocal leukoencephalopathy linked to TecfideraA fatal case of progressive multifocal leukoencephalopathy has been reported for the first time in a patient receiving dimethyl fumarate (Tecfidera).…
Strategies to reduce the use of antibiotics in animals New drugs that could eventually replace or reduce the use of antibiotics in animals are in development to help slow the rise of antibiotic resistance.…